Copyright © BiotechBlog.com, a product of thinkBiotech.comThis is a guest post from Cliff Cramer, Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Do you have a response to Cramer’s post? Post them in the comments section below.
Multi-national [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comThis is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below.
The recent editorial on “Intellectual property and biotechnology [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comThis is my initial response to the Kyoto Prize, which I was able to attend on a fellowship from Point Loma Nazarene University. For more details on the Kyoto Prize see my previous post.
I had an opportunity [...]
At a recent event on the comparative advantages of small molecule vs. biologic drugs, several themes emerged which led me to re-examine the question of whether the practice of medicine is capable of keeping pace with medical innovation.
As mentioned in a [...]
With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:
I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.
This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in October 2009 Tradename Applicant Generic Name Patent Number Patent Expiration BREATHTEK UBT FOR H-PYLORI Otsuka America urea, c-13 4,830,010 Oct 27, 2009 CEDAX Sciele Pharma Inc ceftibuten dihydrate 4,634,697 Oct 1, 2009 COLGATE TOTAL Colgate Palmolive sodium fluoride; triclosan 5,156,835 Oct 20, 2009 COVERA-HS Gd Searle Llc verapamil hydrochloride 5,785,994 Oct 22, 2009 DOXIL Ortho Biotech doxorubicin hydrochloride 5,013,556 Oct 20, 2009 DOXIL Ortho Biotech doxorubicin hydrochloride 5,213,804 Oct [...]The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 15, Issue 4
Intellectual property and biotechnology innovation: To protect or not protect? (free [...]
In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comDCbiotech is a high-level networking group based in Washington DC. The objective is to bring together individuals working in, or serving, the biotechnology sector in Washington DC.
For more information, please visit [www.DCbiotech.com] . The [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comCourtesy of DrugPatentWatch.com:
Drug Patent Expirations in September 2009
*Drugs may be covered by multiple patents
With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the tides are turning — ever so slightly — in the favor of biotechnology. The Burrill Report has a good detailed [...]
Biotechnology Industry Organization CEO Jim Greenwood appeared on CNBC’s SquawkBox defending the case for data exclusivity protection for novel biologic drugs. The video appears below. Interestingly, he used the Aspirin vs. Epogen comparison from my book, Building Biotechnology, when [...]
My most recent editorial in the Journal of Commercial Biotechnology, “The impact of the global financial crisis on biotechnology development,” examines the response of governments around the world to their investments in biotechnology and healthcare innovation. It is a theme [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in August 2009
*Drugs may be covered by multiple patents
Copyright © BiotechBlog.com, a product of thinkBiotech.comNaturally Obsessed
“So what is it that you actually do, Dr. Rifkind?” (groan, groan) It didn’t matter if the question [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comThrough August 31st 2009, my books are available at a 20% discount through the links below:
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in July 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration LEVULAN Dusa aminolevulinic acid hydrochloride 5,422,093 Jul 28, 2009 LEVULAN Dusa aminolevulinic acid hydrochloride 6,710,066 Jul 28, 2009 OPTIMARK Mallinckrodt gadoversetamide 5,130,120 Jul 14, 2009 OPTIMARK Mallinckrodt gadoversetamide 5,137,711 Jul 14, 2009 OPTIMARK IN PLASTIC CONTAINER Mallinckrodt gadoversetamide 5,130,120 Jul 14, 2009 OPTIMARK IN PLASTIC CONTAINER Mallinckrodt gadoversetamide 5,137,711 Jul 14, 2009 PAXIL CR Glaxosmithkline paroxetine [...]The July 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 15, Issue 3
Editorial: The impact of the global financial crisis on biotechnology development [...]
Here is a recent keynote I gave for the Delaware Valley Innovation Network. The group is working on coordinating the activities of community colleges — and other parties –Â between the adjacent Delaware, Philadelphia, and New Jersey regions. My objective [...]
I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry:
Can you tell me a little bit about Koronis and [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in June 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration ADVIL COLD AND SINUS Wyeth Cons ibuprofen; pseudoephedrine hydrochloride 5,071,643 Jun 10, 2009 ADVIL COLD AND SINUS Wyeth Cons ibuprofen; pseudoephedrine hydrochloride 5,360,615 Jun 10, 2009 ALLI Glaxosmithkline Cons orlistat 4,598,089 Jun 18, 2009Courtesy of DrugPatentWatch.com
This information [...]
These papers are from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with [...]
This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to [...]
This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to [...]
This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to [...]
In this video Jeremy Abbate, director of global media at Scientific American, and I discuss the worldVIEW project, where we profiled the biotechnology innovation climate around the world on a country-by-country basis. More details on the project are in my [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comWhere are the biotechnology protesters?
Where are the biotechnology protesters?
I’ve enjoyed the conversations I’ve had with biotechnology protest organizers in the past. They are noticably absent from this year’s Biotechnology Industry Organization conference in Atlanta. [...]
After months of preparation, the Scientific American worldVIEW project has launched.
I had the pleasure of serving as lead editorial consultant of this project, and my mission was to cut through the marketing messages and develop a coherent measure of biotechnology innovation [...]
A recent UMD study has found that VCs pay little attention ot the content of business plans.This is not much of a surprise. I’m generally bearish on business plans, but I do recognize their important role.
Having written several business plans [...]
I’ve got two appearances at BIO related to the Scientific American worldView project:
On May 18th I’ll be participating in a press conference at 1pm in room A340
On May 20th I’ll be participating in a roundtable at 3:30 in Thomas B. [...]
For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming liquidations, mergers, and acquisitions, it is important to note that a measure of destruction can benefit industry progress.
Economy Joseph Schumpeter [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in May 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration ADENOSCAN Astellas adenosine 5,070,877 May 18, 2009 CELLCEPT Roche Palo mycophenolate mofetil 4,753,935 May 3, 2009 CELLCEPT Roche Palo mycophenolate mofetil hydrochloride 4,753,935 May 3, 2009 CLOLAR Genzyme clofarabine 5,384,310 May 23, 2009 COMTAN Orion entacapone 5,112,861 May 12, 2009 STALEVO 100 Orion carbidopa; entacapone; levodopa 5,112,861 May 12, 2009 STALEVO 125 Orion carbidopa; entacapone; levodopa 5,112,861 May [...]In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products must “differ significantly in properties with regard to efficacy.” This requirement for a significant improvement in efficacy only applies to drugs [...]
John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH next week. He’s posted his slides and some background readings on his web site at [www.ceruleanllc.com]. These materials will [...]
The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th launch at BIO 2009. One of the objectives for the project was to put marketing-speak aside and objectively measure biotechnology innovation [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration ACIPHEX Eisai Medcl Res rabeprazole sodium 5,035,899 Apr 4, 2009 CASODEX Astrazeneca bicalutamide 4,636,505 Apr 1, 2009 GENESA Gensia Automedics arbutamine hydrochloride 5,108,363 Apr 28, 2009 MALARONE Glaxosmithkline atovaquone; proguanil hydrochloride 5,053,432 Apr 1, 2009 MALARONE PEDIATRIC Glaxosmithkline atovaquone; proguanil hydrochloride 5,053,432 Apr 1, 2009 MEPRON Glaxosmithkline atovaquone 5,053,432 Apr 1, 2009 PREFEST Duramed estradiol; norgestimate 5,108,995 Apr [...]Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not so, if history decides to repeat itself.
Roche has already bought (and sold) Genentech once before. It’s not unimaginable to think that [...]
I’ll be giving a talk at the Johns Hopkins Carey Business School Entrepreneurship Conference on March 21st titled “Entrepreneurship: What Not to Do.” The talk will cover cases in failed entrepreneurship in biotechnology, elucidating some of the forseeable and unforseeable [...]
The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited by Arlen Meyers.
The links below will take you to the abstract for each paper:
Volume 15, Issue 2
Editorial
[...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in March 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration CLARINEX Schering desloratadine 4,863,931 Mar 15, 2009 CLARINEX Schering Plough desloratadine 4,863,931 Mar 15, 2009 CLARITIN-D Schering Plough loratadine; pseudoephedrine sulfate 4,863,931 Mar 15, 2009 LIDODERM Teikoku Pharma Usa lidocaine 5,589,180 Mar 17, 2009 LIDODERM Teikoku Pharma Usa lidocaine 5,709,869 Mar 17, 2009 NUTROPIN Genentech somatropin recombinant 5,096,885 Mar 17, 2009 PRANDIMET Novo Nordisk Inc metformin [...]I am extending my “Best Practices in Biotechnology” book series with additional books in specific niches in biotechnology commercialization. This project is based on my observation that details on many of the critically important elements in biotechnology business development - [...]
I’ll be giving a talk at the Kogod School of Business on Tuesday February 24th on “Drug Development – Balancing National and Commercial Needs”. The basis of the talk is that countries need access to medicines, foreign currency, and tax revenues, [...]
I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th 2009. My focus will be providing an extensive overview of the biotechnology industry and insights on paths to entrepreneurship and [...]
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in February 2009*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration FERIDEX I.V. Amag Pharms Inc ferumoxides 5,102,652 Feb 6, 2009 IMITREX Glaxosmithkline sumatriptan 5,037,845 Feb 6, 2009 IMITREX Glaxosmithkline sumatriptan succinate 5,037,845 Feb 6, 2009 IMITREX STATDOSE Glaxosmithkline sumatriptan succinate 5,037,845 Feb 6, 2009 TESLASCAN Ge Healthcare mangafodipir trisodium 5,091,169 Feb 25, 2009Courtesy of DrugPatentWatch.com
Want to receive [...]
Copyright © BiotechBlog.com, a product of thinkBiotech.comGuest content from John Avellanet, managing director and principal of Cerulean Associates:
Solving the FDA CrisisBy John Avellanet, Managing Director and Principal of Cerulean Associates LLC
News of the latest crisis under [...]
Guest content from Sandy Graham, managing partner at Sequoyah Associates:
A Business Plan is the single most important document you will develop in establishing and growing your business. How your business plan is developed is certainly up to you. Either [...]
BiotechBistro.com is a new biotechnology community forum attached to BiotechBlog. Topic titles from BiotechBistro are listed on the BiotechBlog homepage (look down the left sidebar), making it an excellent outlet to start productive discussions or announce new products.
BiotechBistro is [...]
